Mount Sinai's AI-powered ECG tool now predicts individual risk for hypertrophic cardiomyopathy (HCM), enabling faster ...

Researchers have calibrated an AI algorithm to more specifically identify patients with hypertrophic cardiomyopathy (HCM), a ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an ...

A team of US researchers, studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) said they have ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify ...

Hypertrophic cardiomyopathy, or HCM ... or after an abnormal electrocardiogram (EKG). Typically, EKGs are administered during ...

“It’s exciting to see the growing real-world evidence showing how AI-enhanced ECG analysis can play a pivotal role in identifying new patients with hypertrophic cardiomyopathy,” said Milind ...

Hypertrophic cardiomyopathy is the leading etiology worldwide, followed by coronary artery anomalies. Recommendations for pre-participation screening ECG-based pre-participation screening (PPS ...

Cardiovascular magnetic resonance imaging (CMRI) has emerged as an important imaging modality for the diagnosis, management and risk stratification of patients with hypertrophic cardiomyopathy (HCM).

ECG denotes electrocardiogram; HCM–, hypertrophic cardiomyopathy negative; and HCM+, hypertrophic cardiomyopathy positive. Mount Sinai researchers studying a type of heart disease known as ...